文献速递白血病淋巴瘤

NOTCH1-MYC通路在T细胞急性淋巴细胞白血病中的作用

The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
PubMed 文献 · Blood · 2017-01-23

T细胞急性淋巴细胞白血病(T-ALL)中,超过65%的患者存在NOTCH1基因激活突变,导致配体非依赖性持续NOTCH1受体信号,激活合成代谢相关转录程序。MYC癌基因在NOTCH1诱导的转化中起主要作用,NOTCH1的致癌活性严格依赖MYC上调,使NOTCH1-MYC调控环路成为有吸引力的治疗靶点。

要点

  • 超过65%的T-ALL患者存在NOTCH1基因激活突变,驱动配体非依赖性持续受体信号。
  • NOTCH1信号激活以合成代谢通路基因上调为主的广泛转录程序。
  • NOTCH1在T-ALL中的致癌活性严格依赖MYC上调,NOTCH1-MYC环路为潜在治疗靶点。

核心结论

  • NOTCH1-MYC调控环路是治疗T-ALL的有吸引力的治疗靶点。

研究设计与样本

  • 综述,总结NOTCH1-MYC通路在T-ALL发病中的作用。

主要发现

  • T-ALL中超过65%的患者因NOTCH1基因激活突变而激活致癌NOTCH信号。
  • NOTCH1突变导致配体非依赖性和持续NOTCH1受体信号,激活以合成代谢通路基因上调为主的广泛转录程序。
  • MYC癌基因在NOTCH1诱导的转化中起主要作用,NOTCH1的致癌活性严格依赖MYC上调。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

T-cell acute lymphoblastic leukemia (T-ALL) is a highly proliferative hematologic malignancy that results from the transformation of immature T-cell progenitors. Aberrant cell growth and proliferation in T-ALL lymphoblasts are sustained by activation of strong oncogenic drivers promoting cell anabolism and cell cycle progression. Oncogenic NOTCH signaling, which is activated in more than 65% of T-ALL patients by activating mutations in the NOTCH1 gene, has emerged as a major regulator of leukemia cell growth and metabolism. T-ALL NOTCH1 mutations result in ligand-independent and sustained NOTCH1-receptor signaling, which translates into activation of a broad transcriptional program dominated by upregulation of genes involved in anabolic pathways. Among these, the MYC oncogene plays a major role in NOTCH1-induced transformation. As result, the oncogenic activity of NOTCH1 in T-ALL is strictly dependent on MYC upregulation, which makes the NOTCH1-MYC regulatory circuit an attractive therapeutic target for the treatment of T-ALL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Sanchez-Martin M, Ferrando A. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood. 2017. PMID: 28115368. doi:10.1182/blood-2016-09-692582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。